Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Arbutus Biopharma Corp as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- +7 vs. Q4 2023
- Shares held
- 83.4M
- +4.46M (+5.6%) vs. Q4 2023
- Total value
- $215.2M
- +$17.8M (+9.0%) vs. Q4 2023
- New holders
- 20
- 32 more added
- Sold out
- 13
- 35 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 176 | $674.9M |
| Q1 2026 | 167 | $625.4M |
| Q4 2025 | 172 | $586.9M |
| Q3 2025 | 166 | $536.4M |
| Q2 2025 | 163 | $365.0M |
| Q1 2025 | 168 | $390.1M |
| Q4 2024 | 154 | $340.3M |
| Q3 2024 | 144 | $389.2M |
| Q2 2024 | 131 | $298.4M |
| Q1 2024 | 119 | $215.2M |
| Q4 2023 | 112 | $197.4M |
| Q3 2023 | 99 | $143.8M |
| Q2 2023 | 111 | $152.4M |
| Q1 2023 | 122 | $189.3M |
| Q4 2022 | 114 | $126.3M |
| Q3 2022 | 127 | $89.1M |
| Q2 2022 | 113 | $120.0M |
| Q1 2022 | 119 | $130.6M |
| Q4 2021 | 123 | $154.4M |
| Q3 2021 | 100 | $149.8M |
| Q2 2021 | 91 | $87.6M |
| Q1 2021 | 94 | $86.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Arbutus Biopharma Corp; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boothbay Fund Management, LLC | 612,277 | $1.58M | 0.05% | +158,649+35.0% | Added |
| Corbin Capital Partners, L.P. | 853,304 | $2.20M | 3.93% | +853,304 | New |
| Northern Trust Corp | 1,056,604 | $2.73M | 0.00% | −11,617−1.1% | Reduced |
| Centiva Capital, LP | 1,352,880 | $3.49M | 0.20% | −67,840−4.8% | Reduced |
| Advisor Group Holdings, Inc. | 1,367,539 | $3.53M | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,995,804 | $5.15M | 0.00% | +61,846+3.2% | Added |
| BlackBarn Capital Partners LP | 2,070,900 | $5.34M | 3.09% | +2,070,900 | New |
| ADAR1 Capital Management, LLC | 2,074,183 | $5.35M | 1.46% | −1,394,641−40.2% | Reduced |
| State Street Corp | 2,611,890 | $6.74M | 0.00% | +215,130+9.0% | Added |
| Geode Capital Management, LLC | 2,958,887 | $7.63M | 0.00% | +141,192+5.0% | Added |
| Adage Capital Partners GP, L.L.C. | 3,000,000 | $7.74M | 0.01% | +3,000,000 | New |
| FourWorld Capital Management LLC | 3,000,527 | $7.74M | 7.55% | +1,909,676+175.1% | Added |
| Hudson Bay Capital Management LP | 3,520,382 | $9.08M | 0.08% | −619,522−15.0% | Reduced |
| Woodline Partners LP | 4,070,659 | $10.5M | 0.10% | −649,244−13.8% | Reduced |
| Vanguard Group Inc | 5,987,907 | $15.4M | 0.00% | −9760.0% | Reduced |
| Two Seas Capital LP | 7,841,927 | $20.2M | 3.96% | −1,200,000−13.3% | Reduced |
| Morgan Stanley | 8,830,297 | $22.8M | 0.00% | +1,846,185+26.4% | Added |
| BlackRock Inc. | 10,404,619 | $26.8M | 0.00% | +14,319+0.1% | Added |
| Whitefort Capital Management, LP | 12,862,152 | $33.2M | 20.21% | −334,910−2.5% | Reduced |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −817,574−100.0% | Sold out |
| Tejara Capital Ltd | 0 | $0 | 0.00% | −180,077−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −105,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −42,736−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −35,820−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,923−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Brown, Lisle/Cummings, Inc. | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −7,192−100.0% | Sold out |
| DAGCO, Inc. | 0 | $0 | 0.00% | −6,300−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,685−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |